We are live on
!
Find out more
AbbVie
ABBV
ABBV
3,816 hedge funds and large institutions have $270B invested in AbbVie in 2025 Q1 according to their latest regulatory filings, with 263 funds opening new positions, 1,493 increasing their positions, 1,621 reducing their positions, and 124 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
2% more funds holding
Funds holding: 3,742 → 3,816 (+74)
0.5% more ownership
Funds ownership: 72.32% → 72.82% (+0.5%)
8% less repeat investments, than reductions
Existing positions increased: 1,493 | Existing positions reduced: 1,621
Holders
3,816
Holding in Top 10
246
Calls
$3.94B
Puts
$3.43B
Top Buyers
| 1 | +$1.08B | |
| 2 | +$747M | |
| 3 | +$582M | |
| 4 |
Goldman Sachs
New York
|
+$555M |
| 5 |
Barclays
London,
United Kingdom
|
+$531M |
Top Sellers
| 1 | -$1.55B | |
| 2 | -$583M | |
| 3 | -$422M | |
| 4 |
Amundi
Paris,
France
|
-$328M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$260M |